About Sollers

Sollers is a graduate school located in New Jersey, specializing in clinical research, drug safety and pharmacovigilance training.

Our graduate certificate and masters programs cover a wide range of subjects tailored to this fast growing industry, and our graduates go on to highly successful careers in the pharmaceuticals industry and healthcare industries.

  • Monday - Thursday | 10 AM - 7 PM
  • Friday | 12 PM - Midnight
  • Saturday | 12 PM - Midnight
  • Sunday | Closed
  • OPEN 24/7 - sollers.edu
    • PHONE
    • (848) 299-5900
    • Location
    • 100 Menlo Park, Suite 550
      Edison New Jersey 08837 -2488


Call Us Now: 848-480-0098

Disruptive Innovations in Clinical Trials- An Overview

Posted by Doctor Erick on Aug 4, 2017 3:15:44 PM

In fact, it is really a challenging task to identify disruptive thinkers in clinical trials for the stakes are very high in the present trend. There are some of the dedicated forums conducted around the US in a delightful manner to instil potential thoughts out of people with an in-depth understanding of existing scenario in clinical trials. Such forums will be conducted as an annual event which can be relied upon by life science industry for the latest thinking in clinical trials for 21st-century drug development.

Although the idea is technically a daunting task, such industry forums showcase the ability of radical thinking about different ways in which the clinical trials are performed. Since the launch of such events, there are about 125 disruptive thinkers who are very eager to discuss and make a significant change in the current solutions in clinical development, propose innovative changes and commit to testing and sharing the results in order to transform drug development and industry.

CR 790.jpg

The initial phases of forums addressed various adaptive design thinking, address virtual clinical trial models, and signify the role of EHRs in clinical data, telemedicine, open source and self-reported patient data among several other ideas. After its inception, a lot of people from leading life sciences started feeling comfortable without getting into depression zone. “As far as innovative ideas are concerned these forums are best and provide a great platform to meet people of a disruptive nature especially in The Conference Forum's Disruptive Innovations to Advance Clinical Trials event, “said Robert Wright, a leading life science leader.

The forums on Disruptive innovations in clinical trials soon flourished and the concept of implementing disrupting thinking had hit the bull's eye (Attendees bearing clinical titles with clinical innovation in them). Subsequent annual programs on disruptive thinking started addressing a jam-packed agenda on the latest innovative thinking to advance clinical trials. Although not all innovation is disruptive, a comprehensive insight is required as a community to drive changes that help bring down millions of dollars in clinical trials. On the other side, it enhances the patient experience bringing more drugs to those who need them a lot at the primary level. The concept of disruptive innovations can be defined in different forms with respect to the purpose it serves for clinical trials. 

The president of Medidata Solutions, Glan de Vries defined it as the way to perform activities that are designed to be carried out by high profile professionals in high-cost venues. It also makes the process affordable and flexible in such a way that it could be done by less skilled people in more convenient and lower cost settings. As opposed to being disruptive an innovation that helps these highly trained professionals make them do their job more efficiently and in a more sophisticated way. In other words, it would implement all the techniques that support to sustain the established ecosystem.

Life sciences companies should have to get the approval for their new therapies including designing trials, enrolling and recruiting the right patients, delivering approved therapies to patients besides ensuring its efficacy, patient progress monitoring, making sure the necessary compliance to the plan, refining and analyzing the results and then submitting them to regulators for approval. All these activities will have its requirement and credibility as long as the job of the clinical trial remains constant. However, the approaches to accomplish them might change from time to time.

Some of the important tools and phases that Life science companies take care of in order to increase their profitability are site selection tools, risk-based monitoring, electronic investigator payments, electronic patient pre-regulation, consent and screening, and site training and credentialing. Therefore in future, there are a plethora of opportunities available for both established companies and entrepreneurs to help build disruptive value network.

Clinical Trial Management
Learn from 300+ hours of an interactive session with industry faculty and clinical experts. Get hands-on training on CTMS, ETMF, and RDC along with 20 weeks internship in Clinical Trial Management.

Join today! Become a Clinical Research Professional!
For more information please contact 1-848-299-5900 or mail admissions@sollers.edu

Topics: Clinical Research